Building different mouse models for human MS

Annals of the New York Academy of Sciences

Volumn 1103, Issue , 2007, Pages 11-18

  Bettelli, Estelle ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Center for Neurologic Diseases   (United States)

Author keywords

2D2; B cells; Devic's disease; EAE; MOG; MS; Optic neuritis; T cells; TH

Indexed keywords

MYELIN OLIGODENDROCYTE GLYCOPROTEIN; T LYMPHOCYTE RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ARTICLE; DISEASE SEVERITY; EXPERIMENTAL MODEL; KNOCKOUT MOUSE; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NONHUMAN; OPTIC NEURITIS; PARENCHYMA; TRANSGENIC MOUSE;

MUS; MUS MUSCULUS;

EID: 34249060003     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1394.021     Document Type: Article

References (49)

1. LASSMANN, H. 1998. Pathology of multiple sclerosis. In McAlpine's Multiple Sclerosis. A. Compston, et al, Eds.: 323-358. Churchill Livingstone. Hong Kong.
2. GHEZZI, A. et al. 1999. Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests. J. Neurol. 246: 770-775.
3. SODERSTROM, M. 2001. Optic neuritis and multiple sclerosis. Acta Ophthalmol. Scand. 79: 223-227.
4. ZAMVIL, S. S. et al. 1986. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 324: 258-260.
5. TUOHY, V. K. et al. 1989. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142: 1523-1527.
6. GREER, J. M. et al. 1992. Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice. J. Immunol. 149: 783-788.
7. GREER, J. M. et al. 1996. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J. Immunol. 156: 371-379.
8. MENDEL, I., N. KERLERO deROSBO & A. BEN-NUN. 1995. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 25: 1951-1959.
9. LININGTON, C. et al. 1993. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23: 1364-1372.
10. AMOR, S. et al. 1994. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153: 4349-4356.
11. KERLERO DE ROSBO, N., I. MENDEL & A. BEN-NUN. 1995. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes. Eur. J. Immunol. 25: 985-993.
12. GENAIN, C. P. & S. L. HAUSER. 1996. Allergic encephalomyelitis in common marmosets: pathogenesis of a multiple sclerosis-like lesion. Methods 10: 420-434.
13. ADELMANN, M. et al. 1995. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J. Neuroimmunol. 63: 17-27.
14. SUN, J. et al. 1991. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J. Immunol. 146: 1490-1495.
15. BERGER, T. et al. 1997. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab. Invest. 76: 355-364.
16. RAINE, C. S. et al. 1980. Optic neuritis and chronic relapsing experimental allergic encephalomyelitis: relationship to clinical course and comparison with multiple sclerosis. Lab. Invest. 42: 327-335.
17. HAYREH, S. S. et al. 1981. Experimental allergic encephalomyelitis. I. Optic nerve and central nervous system manifestations. Invest. Ophthalmol. Vis. Sci. 21: 256-269.
18. HAYREH, S. S. 1981. Experimental allergic encephalomyelitis. II. Retinal and other ocular manifestations. Invest. Ophthalmol. Vis. Sci. 21: 270-281.
19. HU, P. et al. 1998. Microvascular and cellular responses in the optic nerve of rats with acute experimental allergic encephalomyelitis (EAE). Brain Pathol. 8: 475-486.
20. LAFAILLE, J. J. et al. 1994. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78: 399-408.
21. GOVERMAN, J. et al. 1993. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 72: 551-560.
22. WALDNER, H. et al. 2000. Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor. Proc. Natl. Acad. Sci. USA 97: 3412-3417.
23. MADSEN, L. S. et al. 1999. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat. Genet. 23: 343-347.
24. BETTELLI, E. et al. 2003. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197: 1073-1081.
25. MISU, T. et al. 2002. Pure optic-spinal form of multiple sclerosis in Japan. Brain 125: 2460-2468.
26. WINGERCHUK, D. M. & B. G. WEINSHENKER. 2003. Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 60: 848-853.
27. WINGERCHUK, D. M. et al. 1999. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53: 1107-1114.
28. CREE, B. A., D. S. GOODIN & S. L. HAUSER. 2002. Neuromyelitis optica. Semin. Neurol. 22: 105-122.
29. LUCCHINETTI, C. F. et al. 2002. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 125: 1450-1461.
30. KEEGAN, M. et al. 2002. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 58: 143-146.
31. BARON, J. L. et al. 1993. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177: 57-68.
32. KUCHROO, V. K. et al. 1993. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151: 4371-4382.
33. LANGRISH, C. L. et al. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
34. PARK, H. et al. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141.
35. ESIRI, M. M. 1980. Multiple sclerosis: a quantitative and qualitative study of immunoglobulin-containing cells in the central nervous system. Neuropathol. Appl. Neurobiol. 6: 9-21.
36. BARANZINI, S. E. et al. 1999. B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J. Immunol. 163: 5133-5144.
37. QIN, Y. et al. 2003. Intrathecal B-cell clonal expansion, an early sign of humoral immunity, in the cerebrospinal fluid of patients with clinically isolated syndrome suggestive of multiple sclerosis. Lab. Invest. 83: 1081-1088.
38. OWENS, G. P. et al. 2003. Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. J. Immunol. 171: 2725-2733.
39. LENNON, V. A. et al. 2004. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364: 2106-2112.
40. LENNON, V. A. et al. 2005. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 202: 473-477.
41. HJELMSTROM, P. et al. 1998. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination aftermyelin oligodendrocyte glycoprotein sensitization. J. Immunol. 161: 4480-4483.
42. SVENSSON, L. et al. 2002. A comparative analysis of B cell-mediated myelin oligodendrocyte glycoprotein-experimental autoimmune encephalomyelitis pathogenesis in B cell-deficient mice reveals an effect on demyelination. Eur. J. Immunol. 32: 1939-1946.
43. LYONS, J. A. et al. 1999. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 29: 3432-3439.
44. OLIVER, A. R., G. M. LYON & N. H. RUDDLE. 2003. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. J. Immunol. 171: 462-468.
45. LYONS, J. A., M. J. RAMSBOTTOM & A. H. CROSS. 2002. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Eur. J. Immunol. 32: 1905-1913.
46. FILLATREAU, S. et al. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950.
47. BETTELLI, E. et al. 2006. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J. Clin. Invest. 116: 2393-2402.
48. LITZENBURGER, T. et al. 1998. B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J. Exp. Med. 188: 169-180.
49. KRISHNAMOORTHY, G. et al. 2006. Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. J. Clin. Invest. 116: 2385-2392.